Cargando…
The Black Hole: CAR T Cell Therapy in AML
SIMPLE SUMMARY: Unlike B cell malignancies, the progress on generating an adoptive T cell therapy for relapsed/refractory acute myeloid leukemia (AML) remains insufficient. This review focuses on the main challenges in the field and novel strategies to overcome them. ABSTRACT: Despite exhaustive stu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216020/ https://www.ncbi.nlm.nih.gov/pubmed/37345050 http://dx.doi.org/10.3390/cancers15102713 |